COVID-19-vaksiner og epilepsi – Fokus på DEE-populasjon

In conjunction with NIH and our partners at the PCDH19 Alliance, we held this webinar to update DEE families on COVID-19 vaccines and epilepsy. This included updates on the development of vaccines and treatments for COVID-19 and an explanation of how COVID-19 impacts the nervous system, with special consideration for those with developmental and epileptic encephalopathies (DEEs).

Our guests were: Jennifer Holland, a school psychologist and mom to Sloan, who has PCDH19 Epilepsy, who shared her experiences with rescue meds.

Dr. Adam Hartman – the Moderator of this session who is a Program Director at NIH/NINDS and practicing pediatric neurologist.

Dr. Jim Campbell, Associate Professor at University of Maryland School of Medicine – Pediatric Infectious Disease Specialist active in global vaccine research.

Dr. Avindra Nath, is a physician-scientist who specializes in neuroimmunology and is the Intramural Clinical Director of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

This is a recording of the webinar, “Updates on COVID-19 vaccine development with special consideration for the DEE population”, which was held on June 17th, 2020.

Vær oppmerksom på at den mest oppdaterte informasjonen om COVID-19 (Coronavirus) kan ha endret seg siden dette webinaret fant sted.
Besøk gjerne www.cdc.gov/coronavirus for den nyeste informasjonen.

For flere DEE-ressurser, sjekk ut vår resurs senter

Personvernerklæring

Vi erkjenner at personvernet ditt er viktig. Vår personvernerklæring skisserer hvilke typer personopplysninger vi mottar og samler inn når du bruker denne nettsiden, samt noen av trinnene vi tar for å beskytte informasjon. Les mer her.